Answer to Question 1
1
Rationale 1: There is an increased incidence of atypical fractures associated with bisphosphonate use. Thigh or groin pain has been noted to occur prior to fracture.
Rationale 2: Nausea may occur if the patient is on a vitamin D supplement, but this is not the priority.
Rationale 3: Headache may occur if the patient is on a vitamin D supplement, but this is not the priority.
Rationale 4: Skin eruptions are not an effect of bisphosphonate use.
Global Rationale: There is an increased incidence of atypical fractures associated with bisphosphonate use. Thigh or groin pain has been noted to occur prior to fracture. Nausea or headache may occur if the patient is on a vitamin D supplement, but this is not the priority. Skin eruptions are not an effect of bisphosphonate use.
Answer to Question 2
1, 2, 4
Rationale 1: Opioid blockers inhibit both the mu and kappa receptors.
Rationale 2: Some opioids stimulate a particular receptor; others block a receptor.
Rationale 3: Opioid blockers inhibit both the mu and kappa receptors.
Rationale 4: Opioids interact with at least six types of receptors: mu (types one and two), kappa, delta, and nociceptin.
Rationale 5: Opioids interact with at least four types of receptors: mu (types one and two), kappa, delta, and nociceptin.
Global Rationale: Opioid blockers inhibit both the mu and kappa receptors. Some opioids stimulate a particular receptor; others block a receptor. Opioids interact with at least four types of receptors: mu (types one and two), kappa, delta, and nociceptin.
Patient teaching: male genetalia assessment
ROM exercises on a patient’s wrist: flexion.
Areas of sclerosis (see arrows) in the white matter of a patient with MS.
Pneumonia patient’s chest x-ray. Note the irregular areas of density.
Risk assessment codes for an HIV-infected patient.
Edentulous patient with pieces of bone that became necrotic and continued to slough off after tooth ...